APOGEE THERAPEUTICS INC (APGE) Stock Analyst Ratings
NASDAQ:APGE - Nasdaq - US03770N1019 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 90% to APGE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 94.13. This target is 172.45% above the current price.
APGE was analyzed by 14 analysts. The buy percentage consensus is at 90. So analysts seem to be very confident about APGE.
In the previous month the buy percentage consensus was at a similar level.
APGE was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-10 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-12-12 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-12-03 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-12-02 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-11-27 | Guggenheim | Maintains | Buy -> Buy |
| 2024-11-25 | Canaccord Genuity | Initiate | Buy |
| 2024-10-25 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-05-10 | B of A Securities | Initiate | Buy |
| 2024-03-06 | Jefferies | Maintains | Buy -> Buy |
| 2024-03-05 | Guggenheim | Maintains | Buy -> Buy |
| 2024-03-05 | Stifel | Maintains | Buy -> Buy |
| 2024-01-03 | Guggenheim | Maintains | Buy -> Buy |
| 2023-12-20 | BTIG | Initiate | Buy |
| 2023-08-08 | TD Cowen | Initiate | Outperform |
| 2023-08-08 | Guggenheim | Initiate | Buy |
| 2023-08-08 | Stifel | Initiate | Buy |
| 2023-08-08 | Wedbush | Initiate | Outperform |
| 2023-08-08 | Jefferies | Initiate | Buy |